COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Diet, weight status, and physical activity in cancer prevention
- New insight on nutrition and COVID-19 pandemic
- Sleep quality and its relationship with climacteric symptoms and quality of life in women on menopausal transition
- A review of traditional grain-based complementary foods for children aged 6-23 months in selected African countries
- Regional and socio-demographic predictors of dietary proficiency of adolescent girls in Nigeria
- A UV-Visible spectrophotometric approach to quantify caffeine and carbohydrates in Dhaka's chocolate and candy selection, Bangladesh
- Hypertension in Moroccan adults: sociodemographic, lifestyle, and dietary risk factors
- Natural Pectin Sources, Extraction Methods, Chemical Composition, and Emerging Applications in Food Systems: A Systematic Review
- Characterization and Comparative Assessment of the Antioxidant, Antidiabetic, and Antibacterial Potential of Polysaccharide Fractions Extracted from Arbutus unedo L. Fruit
- Metabolic syndrome and risk of colorectal adenoma and colorectal cancer: A meta-analysis
You may also start an advanced similarity search for this article.
NAJFNR is licensed under